Show simple item record

VKORC1 and CYP2C9 polymorphisms are associated with warfarin dose requirements in Turkish patients.

dc.contributor.authorULUTİN, TURGUT
dc.date.accessioned2021-03-05T19:47:24Z
dc.date.available2021-03-05T19:47:24Z
dc.date.issued2008
dc.identifier.citationULUTİN T., "VKORC1 and CYP2C9 polymorphisms are associated with warfarin dose requirements in Turkish patients.", Eur J Clin Pharmacol., cilt.64, ss.889-894, 2008
dc.identifier.othervv_1032021
dc.identifier.otherav_d0ecfa86-664d-4862-8016-7db56b0fe40d
dc.identifier.urihttp://hdl.handle.net/20.500.12627/138110
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/pubmed/18542936
dc.language.isoeng
dc.subjectTemel Bilimler
dc.subjectMoleküler Biyoloji ve Genetik
dc.subjectYaşam Bilimleri
dc.subjectMoleküler Biyoloji ve Genetik
dc.subjectYaşam Bilimleri (LIFE)
dc.titleVKORC1 and CYP2C9 polymorphisms are associated with warfarin dose requirements in Turkish patients.
dc.typeMakale
dc.relation.journalEur J Clin Pharmacol.
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume64
dc.identifier.issue9
dc.identifier.startpage889
dc.identifier.endpage894
dc.contributor.firstauthorID341872


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record